“`html
IC7Fc: A Potential Breakthrough in Treating Both Diabetes and Heart Disease
Published: 2026/01/31 04:58:23
A novel experimental drug, IC7Fc, is showing promising results in preclinical studies as a potential dual therapy for type 2 diabetes and heart disease. Researchers have discovered that this lab-designed cytokine mimetic significantly reduces cholesterol, artery plaque, and inflammation in mice, offering a potential new approach to tackling these interconnected health challenges.
How IC7Fc Works: Targeting Atherosclerosis and Metabolic Disease
IC7Fc is designed to mimic the action of cytokines,signaling molecules that play a crucial role in regulating the immune system and metabolic processes. The research, led by leiden university Medical Center in the Netherlands, in collaboration with Monash University and other partners, and published in Science Advances, demonstrates that IC7Fc effectively combats atherosclerosis – the buildup of plaque in the arteries – a primary driver of heart disease